A detailed history of Jane Street Group, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 126,988 shares of REGN stock, worth $89.1 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
126,988
Previous 143,053 11.23%
Holding current value
$89.1 Million
Previous $150 Million 11.21%
% of portfolio
0.03%
Previous 0.17%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1024.09 - $1201.76 $16.5 Million - $19.3 Million
-16,065 Reduced 11.23%
126,988 $133 Million
Q2 2024

Aug 14, 2024

BUY
$883.2 - $1071.19 $80.3 Million - $97.3 Million
90,879 Added 174.18%
143,053 $150 Million
Q1 2024

May 15, 2024

SELL
$902.69 - $993.35 $19.5 Million - $21.5 Million
-21,629 Reduced 29.31%
52,174 $50.2 Million
Q4 2023

Feb 14, 2024

BUY
$775.18 - $881.7 $26.7 Million - $30.3 Million
34,393 Added 87.27%
73,803 $64.8 Million
Q3 2023

Nov 14, 2023

SELL
$692.45 - $844.37 $21 Million - $25.6 Million
-30,337 Reduced 43.5%
39,410 $32.4 Million
Q2 2023

Aug 14, 2023

BUY
$700.03 - $830.35 $24.7 Million - $29.3 Million
35,238 Added 102.11%
69,747 $50.1 Million
Q1 2023

May 15, 2023

SELL
$680.49 - $826.97 $84.4 Million - $103 Million
-124,036 Reduced 78.23%
34,509 $28.4 Million
Q4 2022

Feb 14, 2023

BUY
$705.89 - $766.39 $25.5 Million - $27.7 Million
36,152 Added 29.54%
158,545 $114 Million
Q3 2022

Nov 14, 2022

BUY
$573.97 - $724.32 $63.6 Million - $80.2 Million
110,784 Added 954.29%
122,393 $84.3 Million
Q3 2022

Nov 14, 2022

BUY
$573.97 - $724.32 $63.6 Million - $80.2 Million
110,784 Added 954.29%
122,393 $84.3 Million
Q2 2022

Aug 16, 2022

SELL
$548.35 - $738.84 $16.2 Million - $21.8 Million
-29,491 Reduced 71.75%
11,609 $6.86 Million
Q1 2022

May 17, 2022

BUY
$595.12 - $698.43 $12.2 Million - $14.4 Million
20,550 Added 100.0%
41,100 $28.7 Million
Q4 2021

Feb 15, 2022

SELL
$543.48 - $670.97 $12 Million - $14.8 Million
-22,122 Reduced 51.84%
20,550 $13 Million
Q3 2021

Nov 16, 2021

SELL
$574.03 - $680.96 $14.5 Million - $17.1 Million
-25,180 Reduced 37.11%
42,672 $25.8 Million
Q2 2021

Aug 16, 2021

BUY
$472.8 - $558.54 $3.56 Million - $4.2 Million
7,526 Added 12.48%
67,852 $37.9 Million
Q1 2021

May 18, 2021

BUY
$446.73 - $548.2 $59,415 - $72,910
133 Added 0.22%
60,326 $28.5 Million
Q4 2020

Feb 17, 2021

BUY
$478.3 - $607.98 $8.58 Million - $10.9 Million
17,932 Added 42.43%
60,193 $29.1 Million
Q3 2020

Nov 17, 2020

BUY
$544.75 - $658.21 $17.4 Million - $21 Million
31,940 Added 309.47%
42,261 $23.7 Million
Q2 2020

Aug 17, 2020

BUY
$493.32 - $643.92 $1.49 Million - $1.95 Million
3,025 Added 41.46%
10,321 $6.44 Million
Q1 2020

May 15, 2020

BUY
$336.18 - $494.43 $1.72 Million - $2.53 Million
5,108 Added 233.46%
7,296 $3.56 Million
Q4 2019

Feb 14, 2020

SELL
$274.13 - $376.51 $1.59 Million - $2.19 Million
-5,809 Reduced 72.64%
2,188 $821,000
Q3 2019

Nov 14, 2019

SELL
$273.46 - $318.39 $4.09 Million - $4.77 Million
-14,969 Reduced 65.18%
7,997 $2.22 Million
Q2 2019

Aug 15, 2019

SELL
$299.6 - $414.82 $10.1 Million - $14 Million
-33,804 Reduced 59.55%
22,966 $7.19 Million
Q1 2019

May 16, 2019

BUY
$372.08 - $439.57 $16.4 Million - $19.4 Million
44,189 Added 351.24%
56,770 $23.3 Million
Q4 2018

Feb 15, 2019

SELL
$335.82 - $403.04 $1.32 Million - $1.58 Million
-3,919 Reduced 23.75%
12,581 $4.7 Million
Q3 2018

Nov 14, 2018

SELL
$351.14 - $408.51 $2.62 Million - $3.05 Million
-7,474 Reduced 31.18%
16,500 $6.67 Million
Q2 2018

Aug 15, 2018

SELL
$284.6 - $344.99 $5.16 Million - $6.26 Million
-18,132 Reduced 43.06%
23,974 $8.27 Million
Q1 2018

May 15, 2018

BUY
$315.82 - $393.78 $8.71 Million - $10.9 Million
27,591 Added 190.09%
42,106 $14.5 Million
Q4 2017

Feb 15, 2018

SELL
$358.63 - $469.95 $6.93 Million - $9.08 Million
-19,316 Reduced 57.1%
14,515 $5.46 Million
Q3 2017

Nov 14, 2017

BUY
$431.38 - $504.0 $14.6 Million - $17.1 Million
33,831
33,831 $15.1 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.